US-based pharmaceutical company BioPharmX will present research to demonstrate the connection between molecular iodine and healthy aging of women’s breasts.

Titled as ‘Molecular Iodine: the Missing Key to Healthy Aging of the Female Breast’, the research is the only poster presentation on female breast health at Vitafoods Europe Conference.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

BioPharmX Regulatory and Clinical affairs executive vice-president AnnaMarie Daniels said: "Our review of literature shows that adequate daily supplementation with molecular iodine yields protection against the development of fibrocystic tissue in breasts.

"Studies have repeatedly shown that taking the right kind of molecular iodine supplements can significantly improve the quality of life for women."

"Studies have repeatedly shown that taking the right kind of molecular iodine supplements can significantly improve the quality of life for women."

The research reviews three studies and has been conducted on more than 2,200 women.

The results conclude that molecular iodine can help gain back normal breast tissue, as well as reduce the symptoms of fibrocystic breast condition (FBC), along with other issues such as breast swelling, tenderness and pain.

At least 70% of premenopausal women are affected by FBC, which occurs when recurrent hormonal exposure increases cell division.

This often results in the formation of fibrous tissue, cysts and chronic inflammation.

BioPharmX has developed a new formulation of molecular iodine that provides the optimal dose required to alleviate FBC symptoms.

The product Violet iodine is commercially available in the US and also a subject of a multicentre clinical trial in women afflicted with moderate to severe FBC.

Vitafoods Europe Conference is an international meeting that discusses on the ingredients and raw materials for the functional food and drink, nutraceutical and nutricosmetics industries.